Hermes Belt Orange
The only side effect that happened more often in people on solanezumab than patients on placebo was chest pain: 1.1% vs. 0.2%.
When the findings of the two studies were looked at individually, patients given solanezumab for 18 months didn't do better on either a test used to measure patients' symptoms or a measure of how well patients are functioning than patients given a placebo.
Other Alzheimer's Drugs in Late Stage TestingThere are more than 5 million Americans living with Alzheimer's disease, which disrupts memory, learning, and other mental functions. In 2010, estimates showed nearly half a million new cases each year, and by 2050, there will be nearly a million new cases annually, according to the Alzheimer's Association.
The findings were presented here at the American Neurological Association meeting.
Oct. 8, 2012 (Boston) An experimental Alzheimer's treatment slowed memory loss by about one third in Gucci Belts Uk
with a sustained cognitive benefit for my mother in law."
amyloid treatment," she says.
The results really became clear when the researchers looked only at Hermes Belt Orange those patients with mild, early stage disease. In the analysis, those given solanezumab had a 34% reduction in memory loss and other mental symptoms compared with those on placebo. There was even a hint that the drug helped to slow the decline in functioning.
Called solanezumab, the drug attaches to a protein called beta amyloid that builds up and clumps together to form sticky plaques that riddle Alzheimer's patients' brains. The drug is designed to prevent those clumps from forming.
Alzheimer's Drug Slows Memory Decline
The benefit is small and studies have been inconsistent, says researcher Rachelle Doody, MD, head of Alzheimer's disease research at Baylor College of Medicine.
The latest results come from a combined analysis of a 1,012 patient study and a 646 patient study, both of which involved people with mild to moderate Alzheimer's disease.
Combining the two studies to give them more statistical power showed that patients on solanezumab didn't lose their memories as quickly as those on placebo.
When A Loved One Has Alzheimer's"While [beta amyloid] is the leading hypothesis of what causes the disease, that has remained unproven. This study may not have hit on everything, and it is not the home run we wanted, but it is the first time we've seen cognitive benefit with an Louis Vuitton Belt Mens Black
people with mild Alzheimer's, offering hope that the drug can alter the course of the progressive disease.
Asked if the 34% improvement in cognitive decline is meaningful to a patient, Carrillo said, "I have a family member with AD. I would be happy Gucci Belt Bag Black
This means that a cookie will stay on your computer even when you exit or close your browser which may reduce your levels of privacy and security. You should never select this option if you're using a publicly accessible computer, or if you're sharing a computer with others. Even if you select this option there are some features of our site that still require you to log in for privacy reasons.
"But the study offers evidence that targeting beta amyloid can benefit patients," she says. Larger studies in many more patients are needed before the drug will be available, though, she says.
Hermes Belt Orange
Hermes Belt Double H